Asarfi Hospital Ltd

Asarfi Hospital Ltd is rated Buy by MarketsMOJO, with this rating last updated on 29 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Asarfi Hospital Ltd has seen its investment rating downgraded from Buy to Hold as of 23 June 2026, reflecting a nuanced reassessment across quality, valuation, financial trends, and technical indicators. Despite robust financial performance and market-beating returns, evolving technical signals and valuation metrics have prompted a more cautious stance from analysts.

Asarfi Hospital Ltd is rated Buy by MarketsMOJO, with this rating last updated on 09 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 June 2026, providing investors with the most recent and relevant data to assess the stock’s potential.

Asarfi Hospital Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The company’s robust quarterly performance, attractive valuation metrics, and improving technical signals have collectively driven this positive revision, signalling renewed investor confidence in the hospital sector micro-cap.

Asarfi Hospital Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 31 May 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trends, and technical outlook.

Asarfi Hospital Ltd, a micro-cap player in the hospital sector, has seen its investment rating downgraded from Buy to Hold as of 19 May 2026. The revision reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate robust financial performance and market-beating returns, evolving technical indicators and valuation metrics have prompted a more cautious stance.

Asarfi Hospital Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 11 May 2026. While the rating adjustment occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 18 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Asarfi Hospital Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a sharp 19.98% decline in its share price on 13 May 2026. This recalibration in valuation metrics, particularly the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positions the micro-cap hospital stock as a compelling opportunity relative to its peers and historical benchmarks.

Asarfi Hospital Limited, a micro-cap healthcare provider with a market capitalisation of ₹402.00 crores, reported a mixed performance for Q4 FY26, with net profit rising 9.19% year-on-year to ₹3.92 crores but declining 27.68% sequentially from Q3 FY26's ₹5.42 crores. The stock tumbled 19.98% following the results announcement, closing at ₹199.60 on May 12, 2026, as investors reacted to the sharp sequential profit decline despite sustained revenue momentum.

A 170.47% stock return in one year. A 161% growth in net profit over the same period. The gap between those two numbers — roughly 9 percentage points — reflects a market that has largely rewarded Asarfi Hospital Ltd for its earnings growth rather than multiple expansion. This close alignment between returns and fundamentals is the key to understanding the stock’s recent performance.

Surging to an all-time high of Rs 254 on 7 Jun 2026, Asarfi Hospital Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 170.47% gain over the past year. This milestone caps a three-day winning streak that has propelled the stock 17.7% higher, underscoring the strength of its technical setup amid a mixed market backdrop.

Extending a three-day winning streak, Asarfi Hospital Ltd surged to a fresh all-time high of Rs 251 on 7 May 2026, outperforming its sector and the broader market with a 2.64% gain on the day.

Asarfi Hospital Ltd has been upgraded from a Buy to a Strong Buy rating by MarketsMOJO as of 6 May 2026, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. The micro-cap hospital sector stock has demonstrated exceptional performance, outpacing benchmarks and signalling strong investor confidence.

Surging to an all-time high of Rs 246 on 6 Jun 2026, Asarfi Hospital Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 166.67% gain over the past year. This milestone caps a sustained rally fuelled by strong technical signals and robust financial performance.

Asarfi Hospital Ltd has reached a significant milestone by touching its all-time high price of Rs 238.00 on 6 May 2026, marking a remarkable achievement in the company’s market journey and reflecting its robust financial performance over recent periods.

Asarfi Hospital Ltd’s investment rating has been revised from Strong Buy to Buy, reflecting nuanced changes across technical indicators, valuation metrics, financial trends, and quality assessments. Despite robust financial performance and market-beating returns, evolving technical signals and valuation considerations have prompted a more cautious stance from analysts.